DT
TRVI icon

Diversified Trust’s Trevi Therapeutics TRVI Stock Holding History

Diversified Trust’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$438K Buy
23,496
+19
+0.1% +$276 0.01% 808
2026
Q1 		$280K Buy
23,477
+2,493
+12% +$27.9K 0.01% 869
2025
Q4 		$263K Buy
20,984
+2,675
+15% +$30.9K ﹤0.01% 869
2025
Q3 		$168K Hold
18,309
– – ﹤0.01% 947
2025
Q2 		$100K Buy
18,309
+3,307
+22% +$20.6K ﹤0.01% 906
2025
Q1 		$94.4K Buy
+15,002
New +$71.6K ﹤0.01% 896

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Diversified Trust's TRVI Position: Q2 2026 in Review

Diversified Trust increased its Trevi Therapeutics (TRVI) stake by 0.08% in Q2 2026, buying an estimated $276 and bringing the position to 23,496 shares worth $438K. The position accounts for 0.01% of the portfolio, ranked #808.

Diversified Trust first reported a position in TRVI in Q1 2025 and has held it in 6 quarters since. 218 funds tracked by Wall St. Rank hold TRVI as of Q2 2026.

  • Diversified Trust held 23,496 shares of Trevi Therapeutics worth $438K as of Q2 2026.
  • Diversified Trust bought 19 Trevi Therapeutics shares in Q2 2026, an estimated $276.
  • Trevi Therapeutics made up 0.01% of Diversified Trust's portfolio in Q2 2026, its #808 holding.
  • Diversified Trust first reported a position in Trevi Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 218 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.